Specifications TableSubject area*Biology*More specific subject area*Demographics, morphology, hemodynamics*Type of data*Tables*How data was acquired*Electrocardiogram(Hf-800b semi-automatic blood biochemical analyzer, HLIFE kangyu medical, jinan, China), Coronary CT (*256-row detector CT scanner \[Revolution CT, GE Healthcare, Milwaukee, USA\], 320--detector row \[Aquilion One; Toshiba, Otawara, Japan\], or dual-source \[Somatom Definition Flash; Siemens, Forchheim, Germany\] CT*), MIMICS (Materialise Company, Belgium), FLUENT (ANSYS Inc., Canonsburg, USA)*Data format*Raw, descriptive*Experimental factors*Age (year), Sex, Myocardial ischemia, Hypertension, Hyperlipidemia, Diabetes mellitus, Smoking, Systolic/Diastolic blood pressure (mmHg), Fasting glucose (mmol/L), Triglycerides (mmol/L), LDL (mmol/L), HDL (mmol/L), Total cholesterol (mmol/L), BMI (kg/m*^*2*^*), L/W (aneurysm shape index), Mean D*~*fit*~*of aneurysm (mm),*$L_{chord\ }/L_{arc}$*, Aneurysm sphericity (*$\varphi$*), SAR-TAWSS, SAR-OSI.*Experimental features*ST segment elevations as well as hyperacute T waves were used for determination of myocardial ischemia. Morphometric data were extracted based on CTA by MIMICS. Hemodynamic data are computed by FLUENT).*Data source location*Beijing Anzhen Hospital, Beijing, China; College of Engineering, Peking University, Beijing, China*Data accessibility*Data is attached with this article*Related research article*Fan T, Zhou Z, Fang W,* et al.*, Morphometry and hemodynamics of coronary artery aneurysms caused by atherosclerosis, Atherosclerosis, 2019;284;187--193*[@bib1].**Value of the data**•This data could be a guideline for the study of functional morphology of CAAs as a result of coronary atherosclerosis.•This data could be helpful for the study of the morphometry and hemodynamics of patient-specific CAAs. Morphological and hemodynamic parameters are provided for 80 CAAs in 61 specific patients.•This data could be used in associated study of the morphology and hemodynamics of CAAs, clinical symptoms (i.e., myocardial ischemia, hypertension, hyperlipidemia) and patient info (i.e., age, gender, smoking and drinking history).

1. Data {#sec1}
=======

The dataset presented in this article describes morphometric and hemodynamic parameters in epicardial coronary arteries of patients with CAAs caused by atherosclerosis. And it also provides the demographics of the CAA study population. There are 61 patients with 80 CAAs, which includes 10 CAAs of type I, 18 CAAs of type II, 29 CAAs of type III and 23 CAAs of type IV. [Table 1](#tbl1){ref-type="table"} and [Table 2](#tbl2){ref-type="table"} list the demographics (e.g., age, myocardial ischemia, diabetes mellitus) of 61 patients. [Table 3](#tbl3){ref-type="table"} and [Table 4](#tbl4){ref-type="table"} list the morphometric parameters (i.e., L/W, $\text{L}_{\text{chord}\ }/\text{L}_{\text{arc}}$, $\varphi$ and Mean Dfit of aneurysm) for type I-IV CAAs. [Table 5](#tbl5){ref-type="table"} and [Table 6](#tbl6){ref-type="table"} list hemodynamic parameters (i.e., SAR-OSI and SAR-TAWSS) for type I-IV CAAs.Table 1Demographics of the type I and II CAA study population with CAAs (type IP1--P7 type II, P8--P18).Table 1N.Age (year)GenderMIHypertensionHyperlipidemiaDMSmokingSystolic blood pressure (mmHg)Systolic blood pressure (mmHg)Fasting glucose (mmol/L)TG (mmol/L)LDL (mmol/L)HDL (mmol/L)TC (mmol/L)BMI (kg/m^2^)**L/W ≥ 2 and CAA covering a bifurcation**P169MYYYNY139965.62.003.011.015.0932P239MYYYNY135864.81.911.230.943.9728.2P362MNYNNY135954.21.052.30.963.3226.5P464MYYNNY116705.61.021.361.023.27742725.2P540MNNYNY110685.32.312.461.043.1711128.6P663MYNNNY110605.81.021.720.952.6326P754MYNNNY109655.91.282.530.893.4924**L/W \< 2 and CAA covering a bifurcation**P873MNYNNY150786.221.532.761.394.728.8P973MYNYNY140754.632.852.231.763.8629.2P1070MNNYNY115785.412.752.721.423.8427.1P1144MYYYNY145736.672.981.321.034.4225.6P1252MNYN\#\#Y136746.371.641.560.823.8229P1352FYYNNN141774.921.652.151.463.8329.8P1452FNYYNN132755.012.011.931.64.1524.5P1561MYNNNN120734.771.652.270.973.7824.9P1659\#\#YNN\#\#N132776.971.551.841.944.425.5P1742MNYNYN115745.921.551.420.514.9023.2P1843\#\#YYYYN132787.532.452.491.014.8520.3Table 2Demographics of the type III and IV CAA study population (type III, P19--P41l; type IV, P42--P461).Table 2No.Age (year)GenderMIHypertensionHyperlipidemiaDMSmokingSystolic blood pressure (mmHg)Systolic blood pressure (mmHg)Fasting glucose (mmol/L)TG (mmol/L)LDL (mmol/L)HDL (mmol/L)TC (mmol/L)BMI (kg/m^2^)**L/W ≥ 2 and CAA in one vessel**P1989MYYNNY130805.760.631.861.053.234.3P2077MYYNNY135864.230.951.910.953.1731.2P2175FNYNNN144885.5112.320.853.6132.5P2263MYYNNY135864.630.951.910.953.1731.5P2357FYYYNN125834.862.972.640.794.431.0P2482MYYYNY1611004.395.122.111.344.3827.9P2553MNNYNY150924.703.012.530.894.6319.0P2644MYYYNY116736.675.421.631.034.4225.9P2731MNNYNY144925.135.573.711.766.2227.5P2841MYNNNN137794.770.712.270.973.625.6P2932MYNNNN83535.840.442.151.293.6417.0P3033MNYYNY148875.32.442.841.045.0328.7P3150MNYYNY124796.372.393.751.077.0722.4P3232MNYYNN122835.082.521.680.883.8710.2P3361MYNNNN137794.770.712.270.973.625.5P3435MNYYNN120804.683.321.910.733.5120.7P3533MYNNNN83535.840.442.151.293.6419.4P3664FNYNNN119705.400.791.670.943.2026.3P3752FNYNNN118736.360.931.860.854.6032.6P3848FNNNNN115584.970.661.731.013.2524.7P3946FNNNNN105794.860.161.901.243.6516.3P4031FNNNNN104585.571.681.751.033.4820.5P4150\#\#NNNNN88725.861.671.800.993.6721.6**L/W \< 2 and CAA in one vessel**P4257MNYYNY125756.221.312.761.394.731.4P4348MYNYYN1207315.0213.582.280.897.4119.1P4474FYYYYY13510014.2913.373.390.966.3828.4P4550MNYYNY148956.372.393.861.077.0728.2P4636MNYYYY1319011.5612.533.210.575.9730.1P4759MYYNNY130805.760.631.861.053.228.1P4862MNYYNN128745.32.063.621.015.3627.9P4962MNNY\#\#Y126775.812.062.521.494.8327.5P5068FYYYNN116797.522.272.520.525.3927.2P5152FNYNNN135755.010.661.931.63.927.1P5254MYNNNY138956.651.282.391.173.9226.8P5382FYYYNN133858.311.533.101.163.1225.9P5452MNNYNN101595.412.563.370.95.7425.8P5569FNYNNN101675.472.872.371.064.3225.1P5661FYYYNY108753.543.672.851.044.4124.8P5752MYYNNY143824.560.581.620.453.6024.3P5861MNNYNY116685.232.342.361.134.4224.0P5958FNNYNN129737.190.662.021.235.3322.8P6053FNNN\#\#N120553.240.452.671.273.8322.6P6140FNNN\#\#N119553.740.362.191.112.5222.5Table 3Morphometric parameters for type I and II CAAs (type I, C1--C10 and type II, C11--C28).Table 3Aneurysm No.Aneurysm shape index (L/W)$\frac{L_{\mathit{chord}\ }}{L_{\mathit{arc}}}$Mean D~fit~ of aneurysm (mm)Aneurysm sphericity ($\phi$)**L/W ≥ 2 and CAAs covering a bifurcation**C13.10.94.60.8C23.00.87.20.9C33.00.87.90.8C42.80.88.70.8C52.70.75.40.8C62.70.96.50.8C72.50.87.30.9C82.50.87.21.0C92.40.97.00.9C102.30.87.10.9**L/W \< 2 and CAAs covering a bifurcation**C111.80.96.70.9C121.70.96.80.7C131.60.94.21.1C141.50.97.30.9C151.40.87.41.2C161.30.93.31.0C171.30.83.40.9C181.30.79.51.0C191.30.96.21.0C201.20.83.41.2C211.20.94.01.3C221.20.74.91.0C231.10.82.70.4C241.10.79.51.0C251.10.73.21.0C261.10.76.20.9C271.10.70.80.1C281.00.86.21.0Table 4Morphometric parameters for type III and IV CAAs (type III, C29--C57 and type IV, C58--C80).Table 4Aneurysm No.Aneurysm shape index (L/W)$\frac{L_{\mathit{chord}\ }}{L_{\mathit{arc}}}$Mean D~fit~ of aneurysm (mm)Aneurysm sphericity ($\phi$)**L/W ≥ 2 and CAAs in one vessel**C295.20.610.20.6C305.10.96.91.0C315.10.77.90.7C324.70.85.40.8C334.70.46.60.7C344.70.85.80.9C354.30.66.40.8C364.10.73.10.8C374.00.86.80.8C383.00.95.11.0C392.90.84.00.9C402.90.66.80.9C412.90.94.50.9C422.80.86.20.9C432.80.64.40.9C442.70.67.91.0C452.70.95.00.8C462.60.84.00.9C472.61.03.20.9C482.50.97.90.7C492.50.73.31.0C502.40.74.20.9C512.40.45.60.8C522.40.82.50.9C532.30.97.90.8C542.20.510.41.0C552.20.84.30.8C562.10.86.20.9C572.00.87.10.7**L/W \< 2 and CAAs in one vessel**C581.90.56.81.2C591.90.83.30.8C601.91.04.91.1C611.80.66.11.2C621.81.16.41.0C631.70.74.50.8C641.60.74.71.0C651.60.72.70.9C661.60.77.90.9C671.60.510.20.9C681.60.94.51.0C691.60.93.81.0C701.50.83.71.1C711.50.82.01.2C721.40.95.00.8C731.40.45.51.0C741.30.82.21.1C751.30.82.71.0C761.30.44.90.9C771.20.94.71.3C781.20.97.51.0C791.10.83.81.0C801.10.93.81.0Table 5Hemodynamic parameters for type I and II CAAs (type I, C1--C10 and type II, C11--C28).Table 5Aneurysm No.SAR-OSI (%)SAR-TAWSS (%)**L/W ≥ 2 and CAAs covering a bifurcation**C113.647.5C214.068.6C311.829.0C48.274.0C56.039.8C64.648.2C70.936.3C80.931.7C97.040.6C100.342.5**L/W \< 2 and CAAs covering a bifurcation**C110.418.8C120.622.9C130.522.1C140.219.6C150.627.1C160.624.6C170.320.8C180.333.0C190.131.9C200.330.5C210.627.5C220.125.7C230.116.5C240.229.1C250.325.4C260.018.7C270.117.0C280.117.0Table 6Hemodynamic parameters for type III and IV CAAs (type III, C29--C57 and type IV, C58--C80).Table 6Aneurysm No.SAR-OSI (%)SAR-TAWSS (%)**L/W ≥ 2 and CAAs in one vessel**C2918.449.0C3018.643.5C3115.039.3C3211.840.4C3317.244.8C3413.938.5C359.020.3C3610.221.4C378.835.8C388.437.2C397.113.5C406.324.9C414.235.2C428.532.1C434.027.4C444.927.9C453.532.0C464.128.5C474.532.7C483.932.0C491.126.0C501.829.0C511.420.3C521.222.2C532.722.7C540.838.3C551.118.2C560.736.6C571.621.0**L/W \< 2 and CAAs in one vessel**C581.114.1C590.99.7C600.514.3C610.68.2C620.319.4C630.112.6C640.49.5C650.321.8C660.16.4C670.224.0C680.120.4C690.05.4C700.127.8C710.120.6C720.016.1C730.012.8C740.11.5C750.00.0C760.14.9C770.010.0C780.10.4C790.01.0C800.12.0

2. Experimental design, materials and methods {#sec2}
=============================================

2.1. Materials {#sec2.1}
--------------

The experiment shows the demographic data for 61 patients (patient numbers, P1--P61) with CAAs, who underwent coronary CT angiography (CTA) of the coronary arteries at the Beijing Anzhen Hospital, Beijing, China. A total of 80 coronary artery aneurysms (CAA number, C1--C80) were identified among these 61 specific patients. Multiple morphometric parameters are also defined. The study was approved by the Institutional Review Board (IRB) for the Beijing Anzhen Hospital, which conforms with the declaration of Helsinki.

2.2. Methods {#sec2.2}
------------

Here, CAAs caused by atherosclerosis are divided into four groups in this data set. As the presence of a coronary artery bifurcation is the main major risk factor for CAAs followed by high aneurysm shape index (L/W, where L and W refer to the aneurysm length and maximum diameter, respectively); the characteristics of CAAs are grouped into type I (L/W ≥ 2 and CAA covering a bifurcation), type II (L/W \< 2 and CAA covering a bifurcation), type III (L/W ≥ 2 and CAA in one vessel), and type IV (L/W \< 2 and CAA in one vessel).

### 2.2.1. Demographic data {#sec2.2.1}

General medical examinations, including medical history collection, blood pressure measurement, blood sampling, and urine analysis were performed. ST segment elevations as well as hyperacuity T waves were used for determination of myocardial ischemia. (Hf-800b semi-automatic blood biochemical analyzer, HLIFE kangyu medical, ji nan, China). Demographics of the study population, including age, sex, myocardial ischemia, hypertension, hyperlipidemia, diabetes mellitus, smoking, blood pressure, fasting blood glucose, triglycerides, cholesterol concentrations, and body mass index are listed in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}.1.LDL: low density lipoprotein2.HDL: high density lipoprotein3.BMI: body mass index4.\#\#: unknown information5.TC: total cholesterol6.TG: triglycerides7.MI: myocardial ischemia8.DM: diabetes mellitus9.DM: diabetes mellitus10.Y: yes11.N: no12.M: male13.F: female

### 2.2.2. Morphometric data {#sec2.2.2}

Similar to previous studies [@bib2], [@bib3], the Coronary CTA was performed through three CT scanners (i.e., 256-row detector CT scanner \[Revolution CT, GE Healthcare, Milwaukee, USA\], 320--detector row \[Aquilion One; Toshiba, Otawara, Japan\], or dual-source \[Somatom Definition Flash; Siemens, Forchheim, Germany\] CT). All studies were of diagnostic image quality with optimal contrast enhancement and no substantial motion artifacts. All digitized data were imported into the MIMICS Innovation Suite platform (Materialise Company, Belgium) for 3D geometry reconstruction. Morphometric data of the epicardial coronary arteries with the CAA, i.e., L/W, $\text{L}_{\text{chord}\ }/\text{L}_{\text{arc}}$, $\varphi$ and Mean Dfit of aneurysm were extracted based on the coronary CTA in each aneurysm (detailed definitions as follows).1.L/W: aneurysm shape index, where W is maximum aneurysm diameter, L is aneurysm length.2.φ: sphericity index=$\ \frac{\text{π}^{1/3} \cdot \left( {6\text{V}} \right)^{2/3}}{\text{A}}$, where V is the aneurysm volume and A is the surface area.3.Mean D~fit~ of aneurysm (mm): the best fit diameter of the aneurysm, D~fit~, is calculated as twice the average radius between the point on the centerline and the contour of the 3D aneurysm vessel.4.$\text{L}_{\text{chord}\ }/\text{L}_{\text{arc}}$: $\text{L}_{\text{chord}\ }$(mm) is the straight length from inlet to outlet of coronary artery and $\text{L}_{\text{arc}}$ (mm) is the accumulative length along the centerline of coronary artery.

The morphometric parameters for type I and II CAAs, which includes 10 type I CAAs and 18 type II CAAs, are listed in [Table 3](#tbl3){ref-type="table"}. The morphometric parameters for Type III and IV CAAs, which includes 29 type III CAAs and 23 type IV CAAs, are listed in [Table 4](#tbl4){ref-type="table"}.

### 2.2.3. Hemodynamic data {#sec2.2.3}

Based on morphometric data, geometrical models were meshed using the ANSYS ICEM software (ANSYS Inc., Canonsburg, USA). The Navier-Stokes and continuity equations were solved using a finite volume solver, FLUENT (ANSYS Inc., Canonsburg, USA), as in previous studies [@bib2], [@bib3]. Three cardiac cycles were required to achieve convergence for the transient analysis. A constant time step was employed, where Δt = 0.01 s with 84 total time steps per cardiac cycle. The aortic pulsatile pressure wave was applied to the inlet of epicardial coronary arterial tree [@bib2]. The resistance boundary condition was assigned to each outlet [@bib2].

The time-averaged wall shear stress (TAWSS) and the oscillatory shear index (OSI) were obtained from the computed flow fields. From the data, we also computed SAR-TAWSS [@bib4], [@bib5] and SAR-OSI [@bib6], [@bib7] within the CAA region (detailed definitions as follows).1.SAR-TAWSS within the CAA region: surface area ratio of low TAWSS ($= \frac{{\text{Surface}\ \text{area}}_{\text{TAWSS} \leq 4\ \text{dynes} \cdot \text{cm}^{- 2}}}{\text{Aneurysmal}\ \text{surface}\ \text{area}} \times 100\text{\%}$) within the CAA region. Surface area of TAWSS ≤4 dyn/cm^2^ indicates the disease-prone site [@bib4], [@bib5].2.SAR-OSI within the CAA region: surface area ratio of high OSI ($= \frac{{\text{Surface}\ \text{area}}_{\text{OSI} \geq 0.15}}{\text{Aneurysmal}\ \text{surface}\ \text{area}} \times 100\text{\%}$) within the CAA region. Surface area of OSI ≥0.15 indicates the disease-prone site [@bib6], [@bib7].

The hemodynamic parameters for type I and II CAAs, which includes 10 type I CAAs and 18 type II, are listed in [Table 5](#tbl5){ref-type="table"}. The hemodynamic parameters for type III and IV CAAs, which includes 29 type III CAAs and 23 type IV CAAs, are listed in [Table 6](#tbl6){ref-type="table"}.
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